NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Fitness & Wellness Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Fitness & Wellness Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hepatic Cancer



Recent findings in hepatic cancer described by researchers from Akita University, Department of Radiology



July 2nd, 2008

A report, 'Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors,' is newly published data in Journal of Magnetic Resonance Imaging. In this recently published article, scientists in Akita, Japan conducted a study "To compare respiratory-triggered T2-weighted fast spin-echo (RTT2W-FSE) and gradient T2*-weighted recalled-echo (T2*W-GRE) images for visualization of malignant hepatic tumors using ferucarbotran-enhanced magnetic resonance (MR) imaging. Ferucarbotran-enhanced RTT2W-FSE and...


Source: Fitness & Wellness Business Week (2008-07-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login